We are live on
!
Find out more
AP
AHL Partners Portfolio holdings
AUM
$6.41B
1-Year Est. Return
23.14%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+23.14%
3 Year Est. Return
+67.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.5B
AUM Growth
+$567M
(+29%)
Cap. Flow
+$507M
Cap. Flow
% of AUM
20.24%
Top 10 Holdings %
Top 10 Hldgs %
5.5%
Holding
888
New
156
Increased
470
Reduced
152
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$25M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.8M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$13.2M |
| 4 |
Invesco Senior Loan ETF
BKLN
|
+$11.3M |
| 5 |
ZU
ZULILY INC CLASS A COMMON STOCK
ZU
|
+$8.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$24.9M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$20.6M |
| 3 |
Invesco S&P 500 Low Volatility ETF
SPLV
|
+$10.7M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$6.23M |
| 5 |
Becton Dickinson
BDX
|
+$5.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 20.67% |
| 2 | Healthcare | 18.65% |
| 3 | Technology | 13.26% |
| 4 | Financials | 11.59% |
| 5 | Industrials | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Eli Lilly
LLY
$1.05T
| $5.56M | 0.22% |
76,468
+36,766
| +93% | +$2.62M |
|
127
Pultegroup
PHM
$24B
| $5.55M | 0.22% |
249,705
+96,589
| +63% | +$2.1M |
|
128
Align Technology
ALGN
$12.7B
| $5.54M | 0.22% |
103,027
+62,839
| +156% | +$3.58M |
|
129
Gilead Sciences
GILD
$167B
| $5.54M | 0.22% |
56,442
+29,811
| +112% | +$3.03M |
|
|
TARO
130
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $5.53M | 0.22% |
39,181
+20,401
| +109% | +$3.14M |
|
131
Aptiv
APTV
$12.2B
| $5.52M | 0.22% |
69,249
+36,229
| +110% | +$2.72M |
|
132
Capri Holdings
CPRI
$1.88B
| $5.52M | 0.22% |
83,948
+66,820
| +390% | +$4.58M |
|
|
HMHC
133
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $5.51M | 0.22% |
234,645
+91,284
| +64% | +$1.88M |
|
134
Waters Corp
WAT
$36.2B
| $5.5M | 0.22% |
44,251
+21,009
| +90% | +$2.51M |
|
|
ADT
135
DELISTED
ADT Corp
ADT
| $5.5M | 0.22% |
132,471
+81,385
| +159% | +$3.05M |
|
136
Amgen
AMGN
$198B
| $5.5M | 0.22% |
34,392
+18,119
| +111% | +$2.85M |
|
137
IQVIA
IQV
$34.4B
| $5.5M | 0.22% |
82,084
+36,897
| +82% | +$2.33M |
|
138
Bio-Rad Laboratories Class A
BIO
$8.15B
| $5.49M | 0.22% |
40,577
+18,935
| +87% | +$2.35M |
|
139
Quest Diagnostics
DGX
$23.3B
| $5.47M | 0.22% |
71,199
+25,704
| +56% | +$1.84M |
|
140
Harley-Davidson
HOG
$2.8B
| $5.42M | 0.22% |
89,145
+53,431
| +150% | +$3.36M |
|
141
Myriad Genetics
MYGN
$584M
| $5.41M | 0.22% |
152,946
+81,593
| +114% | +$2.92M |
|
142
AbbVie
ABBV
$450B
| $5.37M | 0.21% |
91,749
+51,158
| +126% | +$3.09M |
|
143
Thor Industries
THO
$3.97B
| $5.37M | 0.21% |
84,908
+48,694
| +134% | +$2.9M |
|
144
Andersons Inc
ANDE
$2.7B
| $5.36M | 0.21% |
129,573
+15,226
| +13% | +$685K |
|
|
QGENF
145
DELISTED
QIAGEN NV
QGENF
| $5.36M | 0.21% |
212,557
+102,359
| +93% | +$2.58M |
|
146
Charles River Laboratories
CRL
$10.8B
| $5.35M | 0.21% |
67,516
+25,209
| +60% | +$1.86M |
|
147
Waste Management
WM
$96.1B
| $5.35M | 0.21% |
98,588
+56,127
| +132% | +$2.99M |
|
148
Bristol-Myers Squibb
BMY
$124B
| $5.34M | 0.21% |
82,829
+37,777
| +84% | +$2.36M |
|
149
Bio-Techne
TECH
$11.2B
| $5.34M | 0.21% |
213,076
+102,732
| +93% | +$2.44M |
|
150
Polaris
PII
$4.16B
| $5.33M | 0.21% |
37,798
+17,412
| +85% | +$2.57M |
|
Similar funds
RFS
CWAM
CCCA
HTG
GP
IH
GL
TAM
AHL Partners's Q1 2015 Portfolio in Review
As of Q1 2015, AHL Partners held 888 positions worth $2.5B, up 29% from $1.94B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
AHL Partners deployed $507M of net new capital in Q1 2015, opening 156 new positions and adding to 470 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 275,966 shares worth $25M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Vanguard Real Estate ETF, an estimated $20.6M trimmed.
- AHL Partners's largest Q1 2015 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 275,966 shares worth $25M.
- AHL Partners added most to Thomson Reuters in Q1 2015, an estimated $6.01M increase.
- AHL Partners's biggest Q1 2015 reduction was Vanguard Real Estate ETF, cutting an estimated $20.6M.
- AHL Partners fully exited iShares Core US Aggregate Bond ETF in Q1 2015, selling an estimated $24.9M.
- AHL Partners's ten largest holdings make up 5.5% of its $2.5B portfolio in Q1 2015.
- AHL Partners opened 156 new positions and closed 109 in Q1 2015.
- AHL Partners's portfolio value rose 29% quarter-over-quarter to $2.5B.
Based on AHL Partners's 13F filing for Q1 2015, filed 15 May 2015.